A clinical-grade acellular matrix for esophageal replacement

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Biomaterials Science

Background:

• Current esophageal replacement methods involve sacrificing healthy organs, leading to high morbidity and mortality.
• Tissue engineering offers a promising alternative for creating esophageal substitutes using scaffolds and cells.

Purpose of the Study:

• To develop a simple, safe, and effective decellularization process for obtaining clinical-grade esophageal extracellular matrix.
• To evaluate the suitability of the decellularized matrix for potential clinical applications in esophageal repair.

Main Methods:

• Porcine esophagi underwent decontamination followed by decellularization using sodium dodecyl sulfate and ethylenediaminetetraacetic acid in a bioreactor.
• DNA removal was achieved via DNase treatment, and residual detergents were eliminated using an absorbing resin.
• Characterization included DNA quantification, sterility testing, cytotoxicity assessment, and evaluation of biomechanical properties and cell reseeding capacity.

Main Results:

• Complete decellularization was achieved while preserving the native esophageal matrix's structure, composition, and biomechanical properties.
• The process maintained sterility and demonstrated no cytotoxicity.
• The resulting matrix met clinical grade criteria and was successfully reseeded with mesenchymal stem cells.

Conclusions:

• The developed decellularization process yields a clinical-grade esophageal extracellular matrix.
• This scaffold is a promising biomaterial for esophageal tissue engineering, potentially overcoming limitations of current replacement strategies.
• The matrix supports mesenchymal stem cell adhesion and proliferation, indicating its potential for regenerative therapies.